Inferior Vena Cava Diameter and Postpartum Hemorrhage
NCT03732079 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 108
Last updated 2018-11-06
Summary
Excessive bleeding after normal birth or cesarean section is defined as blood loss of 1000 mL or more (clinically estimated) within 24 hours after birth. It occurs in about 5% among postpartum women. Postpartum hemorrhage is a leading cause of morbidity and mortality among women giving birth. Postpartum hemorrhage may lead to hemorrhagic shock, renal failure, respiratory failure, need for surgical intervention, blood transfusion and hysterectomy.
The cornerstone of effective treatment is rapid diagnosis and intervention in time. However, in a number of cases there is an underestimation of the volume of blood loss which may lead to delay in diagnosis and treatment. The consequences are even graver in women who delivered by a cesarean section, since unlike a normal birth in which the bleeding is external and visible, the bleeding is usually intra-abdominal, and so the delay in diagnosis may be even longer.
The Inferior Vena Cava (IVC) is a flexible blood vessel sensitive to intravascular blood volume, and its diameter varies accordingly. Its diameter reflects the pressure in the right atrium, which is a measure of the cardiac preload. A number of studies have shown that the IVC diameter changes, before the variations in vital and clinical signs.
Recently, IVC diameter has been assessed as an assessment of intravenous fluid balance in hemodynamically stable patients with a risk of sub-volume shock. The authors concluded that the IVC measurement is a good noninvasive method, compared to catheter insertion into the right atrium, and it is available as a bedside procedure.
In obstetrics the use of IVC to determine blood loos was not widely examined and there is no information regarding the use of IVC diameter as a predictor or as a detection method of postpartum bleeding.
In this study the investigators aim to examine the correlation between IVC diameter and the volume of postpartum blood loss.
Conditions
- Other Immediate Postpartum Hemorrhage, With Delivery
Interventions
- DIAGNOSTIC_TEST
-
Ultrasound
Ultrasound to measure the IVC diameter. The IVC diameter will be measured in the inspirium and the expirium, and the collapsibility index will be recorded.
Sponsors & Collaborators
-
HaEmek Medical Center, Israel
lead OTHER
Principal Investigators
-
Manal Massalha, Massalha · Emek Medical Center
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-11-10
- Primary Completion
- 2019-04-30
- Completion
- 2019-04-30
- FDA Device
- Yes
More Related Trials
-
Comparing Intramyometrial Tranexamic Acid and Oxytocin for Blood Loss in Cesarean Section
NCT06010368 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Postpartum Hemorrhage: Incidence and Risk Factors
NCT05525143 ·Status: COMPLETED
-
The Impact of "Natural" Cesarean Delivery on Peripartum Maternal Blood Loss.
NCT02768142 ·Status: COMPLETED ·Phase: NA
-
Determination of Blood Loss After CS
NCT04549012 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Abdominal Ultrasound Assessment in the Post-cesarean Patient
NCT02159105 ·Status: COMPLETED
-
Randomization of Oxytocin, Oxytocin+Intrauterine Misoprostol and Carbetocin During C-section
NCT05083910 ·Status: COMPLETED ·Phase: NA
-
A Novel Technique Of Uterine Cooling During Repeated Cesarean Section For Reducing Blood Loss
NCT03793153 ·Status: COMPLETED ·Phase: NA
-
Evaluation the Perfusion of Uterus and Lower Extremities During Cesarean Section With NIRS and Color Doppler
NCT02178774 ·Status: UNKNOWN
-
Carbetocin Versus Oxytocin and Ergometrine for the Prevention of Postpartum Haemorrhage Following Caesarean Section
NCT02101567 ·Status: COMPLETED ·Phase: PHASE4
-
Oxytocin Infusions and Blood Loss in Patients Undergoing Elective Cesarean Delivery.
NCT01932060 ·Status: COMPLETED ·Phase: PHASE3
-
A Novel Tourniquet Technic for Massive PPH
NCT02997397 ·Status: COMPLETED
-
The Prophylactic Role of Tranexamic Acid in High Risk Pregnant Women Undergoing Elective Cesarean Section in Prevention of Postpartum Hemorrhage
NCT05434533 ·Status: COMPLETED ·Phase: PHASE4
-
Intra-myometrial Vasopressin During Cesarean Section in Placenta Previa
NCT03725553 ·Status: COMPLETED ·Phase: NA
-
Prevalance of Cesarean Section Niche in Patients With Abnormal Uterine Bleeding
NCT05067296 ·Status: UNKNOWN
-
Thromboelastography to Assess Hemostatic Changes in Patients Undergoing Elective Cesarean Delivery.
NCT00767832 ·Status: COMPLETED
-
Oxytocin to Decrease Blood Loss During Cesarean Section
NCT00891150 ·Status: COMPLETED ·Phase: NA
-
The Cervical Length and Thickness of Cesarean Section Scar With Preterm Labor
NCT04554745 ·Status: COMPLETED ·Phase: NA
-
Four Different Methods of Performing External Aortic Compression After Caesarean Section
NCT06157307 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Comparing Tranexamic Acid Versus Ecbolics in Preventing Hemorrhage During and After Cesarean Section
NCT06060327 ·Status: COMPLETED ·Phase: NA
-
Mostafa Maged Maneuveur to Prevent and Control Post-partum Haemorrhage During Normal Vaginal Delivery
NCT05288322 ·Status: COMPLETED ·Phase: NA
-
Preload Optimization Guided by Inferior Vena Cava Collapsibility Index
NCT04272580 ·Status: COMPLETED ·Phase: NA
-
Comparison of Blood Loss in Using vs Not Using Placental Cord Drainage After Spontaneous Vaginal Delivery
NCT03020355 ·Status: UNKNOWN ·Phase: NA
-
The Association Between Delivery Method and Maternal Rehospitalization
NCT00501501 ·Status: COMPLETED
-
Prediction of Bleeding in Placenta Previa
NCT05403203 ·Status: UNKNOWN
-
Haemodynamic Effects of Oxytocin and Carbetocin
NCT01277978 ·Status: COMPLETED